StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
PMHS

Polomar Health Services, Inc.

PMHS OTC Pharmaceutical Preparations EDGAR ↗
$0.08
+0.01 +23.08%

Key statistics

from XBRL data in SEC filings
Market cap
$2.24M
Revenue (TTM)
$1.65M
Net income (TTM)
-$10.3M
EPS (TTM)
$-0.37
P/E ratio
Dividend yield
Free cash flow
-$487K
Cash
$87.8K
Total assets
$517K
Gross margin
61.1%
52-week range
$0.07 – $0.80

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K/A Director or officer change; Amended charter or bylaws Jul 30, 2026 8-K Director or officer change Jul 20, 2026 8-K Changed accountants Jul 17, 2026 8-K Director or officer change; Amended charter or bylaws Jul 6, 2026 8-K Terminated a material agreement Jun 15, 2026 10-Q Quarter ended 2026-03-31 Jun 1, 2026 8-K Entered a material agreement; Other events May 15, 2026 10-K Fiscal year ended 2025-12-31 May 6, 2026 8-K Terminated a material agreement Apr 29, 2026 8-K Entered a material agreement Dec 12, 2025 10-Q Quarter ended 2025-09-30 Nov 25, 2025 8-K Entered a material agreement Oct 14, 2025 8-K Entered a material agreement Aug 29, 2025 10-Q Quarter ended 2025-06-30 Aug 19, 2025 8-K Entered a material agreement Jul 29, 2025 8-K Entered a material agreement Jul 25, 2025 8-K Entered a material agreement Jul 24, 2025 8-K Entered a material agreement; Terminated a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Amended charter or bylaws Jul 9, 2025 10-Q Quarter ended 2025-03-31 Jun 30, 2025 10-K Fiscal year ended 2024-12-31 May 22, 2025 8-K Director or officer change; Other events Apr 16, 2025 8-K Entered a material agreement Mar 17, 2025 10-Q/A Quarter ended 2024-09-30 Mar 7, 2025 8-K Previously issued financials not reliable Mar 5, 2025 8-K Entered a material agreement Jan 14, 2025 10-Q Quarter ended 2024-09-30 Nov 19, 2024 8-K/A Entered a material agreement; Took on a direct financial obligation Nov 12, 2024 8-K/A Completed an acquisition or disposition Oct 25, 2024 8-K Amended charter or bylaws Oct 17, 2024 8-K Entered a material agreement; Completed an acquisition or disposition; Unregistered sale of equity; Change in control; Director or officer change Oct 4, 2024 8-K Unregistered sale of equity Sep 20, 2024 8-K Entered a material agreement; Took on a direct financial obligation Aug 21, 2024 10-Q Quarter ended 2024-06-30 Aug 14, 2024 8-K Director or officer change Jul 23, 2024 8-K Shareholder vote results Jul 17, 2024 8-K Entered a material agreement Jul 5, 2024 8-K Entered a material agreement Jul 2, 2024 10-Q Quarter ended 2024-03-31 May 15, 2024 10-K Fiscal year ended 2023-12-31 Apr 15, 2024 8-K Director or officer change Mar 25, 2024